Leading the way in digital health with
a new generation of drug delivery
and biosensing devices
Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. Our microchip-based implant has the potential to address significant unmet needs by simplifying dosing regimens and enhancing compliance for patients who need frequent dosing or require regular injections. We are developing applications for the microchip-based implant in multiple therapeutic indications including osteoporosis, diabetes, multiple sclerosis and women’s contraception and we are partnering with industry and foundations to meet patient needs across the globe.
Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery
Our proprietary microchip-based implant can enhance the utility and compliance of established agents requiring frequent, long-term dosing
Latest News
June 18, 2015
Teva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery Technology
View Article
February 5, 2015
Microchips Biotech, Inc. CEO Cheryl R. Blanchard, Ph.D., Elected to National Academy of Engineering
View Article